131 related articles for article (PubMed ID: 10411304)
1. Estrogen receptor binding to estrogen response elements slows ligand dissociation and synergistically activates reporter gene expression.
Klinge CM
Mol Cell Endocrinol; 1999 Apr; 150(1-2):99-111. PubMed ID: 10411304
[TBL] [Abstract][Full Text] [Related]
2. Role of estrogen receptor ligand and estrogen response element sequence on interaction with chicken ovalbumin upstream promoter transcription factor (COUP-TF).
Klinge CM
J Steroid Biochem Mol Biol; 1999 Nov; 71(1-2):1-19. PubMed ID: 10619353
[TBL] [Abstract][Full Text] [Related]
3. Estrogen response element binding induces alterations in estrogen receptor-alpha conformation as revealed by susceptibility to partial proteolysis.
Ramsey TL; Klinge CM
J Mol Endocrinol; 2001 Dec; 27(3):275-92. PubMed ID: 11719281
[TBL] [Abstract][Full Text] [Related]
4. Comparison of tamoxifen ligands on estrogen receptor interaction with estrogen response elements.
Klinge CM; Studinski-Jones AL; Kulakosky PC; Bambara RA; Hilf R
Mol Cell Endocrinol; 1998 Aug; 143(1-2):79-90. PubMed ID: 9806352
[TBL] [Abstract][Full Text] [Related]
5. Stability of the ligand-estrogen receptor interaction depends on estrogen response element flanking sequences and cellular factors.
Anolik JH; Klinge CM; Brolly CL; Bambara RA; Hilf R
J Steroid Biochem Mol Biol; 1996 Dec; 59(5-6):413-29. PubMed ID: 9010347
[TBL] [Abstract][Full Text] [Related]
6. Dissociation of 4-hydroxytamoxifen, but not estradiol or tamoxifen aziridine, from the estrogen receptor as the receptor binds estrogen response element DNA.
Klinge CM; Traish AM; Bambara RA; Hilf R
J Steroid Biochem Mol Biol; 1996 Jan; 57(1-2):51-66. PubMed ID: 8645617
[TBL] [Abstract][Full Text] [Related]
7. Site-directed estrogen receptor antibodies stabilize 4-hydroxytamoxifen ligand, but not estradiol, and indicate ligand-specific differences in the recognition of estrogen response element DNA in vitro.
Klinge CM; Traish AM; Driscoll MD; Hilf R; Bambara RA
Steroids; 1996 May; 61(5):278-89. PubMed ID: 8738832
[TBL] [Abstract][Full Text] [Related]
8. Chicken ovalbumin upstream promoter-transcription factor interacts with estrogen receptor, binds to estrogen response elements and half-sites, and inhibits estrogen-induced gene expression.
Klinge CM; Silver BF; Driscoll MD; Sathya G; Bambara RA; Hilf R
J Biol Chem; 1997 Dec; 272(50):31465-74. PubMed ID: 9395481
[TBL] [Abstract][Full Text] [Related]
9. Antiestrogen-liganded estrogen receptor interaction with estrogen responsive element DNA in vitro.
Klinge CM; Bambara RA; Hilf R
J Steroid Biochem Mol Biol; 1992 Oct; 43(4):249-62. PubMed ID: 1390277
[TBL] [Abstract][Full Text] [Related]
10. Differential impact of flanking sequences on estradiol- vs 4-hydroxytamoxifen-liganded estrogen receptor binding to estrogen responsive element DNA.
Anolik JH; Klinge CM; Bambara RA; Hilf R
J Steroid Biochem Mol Biol; 1993 Dec; 46(6):713-30. PubMed ID: 8274405
[TBL] [Abstract][Full Text] [Related]
11. Cooperative binding of estrogen receptor to DNA depends on spacing of binding sites, flanking sequence, and ligand.
Anolik JH; Klinge CM; Hilf R; Bambara RA
Biochemistry; 1995 Feb; 34(8):2511-20. PubMed ID: 7873531
[TBL] [Abstract][Full Text] [Related]
12. Footprint analysis of estrogen receptor binding to adjacent estrogen response elements.
Driscoll MD; Klinge CM; Hilf R; Bambara RA
J Steroid Biochem Mol Biol; 1996 Apr; 58(1):45-61. PubMed ID: 8809185
[TBL] [Abstract][Full Text] [Related]
13. The aryl hydrocarbon receptor (AHR)/AHR nuclear translocator (ARNT) heterodimer interacts with naturally occurring estrogen response elements.
Klinge CM; Bowers JL; Kulakosky PC; Kamboj KK; Swanson HI
Mol Cell Endocrinol; 1999 Nov; 157(1-2):105-19. PubMed ID: 10619402
[TBL] [Abstract][Full Text] [Related]
14. Allosteric silencing of activating function 1 in the 4-hydroxytamoxifen estrogen receptor complex is induced by substituting glycine for aspartate at amino acid 351.
MacGregor Schafer J; Liu H; Bentrem DJ; Zapf JW; Jordan VC
Cancer Res; 2000 Sep; 60(18):5097-105. PubMed ID: 11016635
[TBL] [Abstract][Full Text] [Related]
15. Effect of antagonists on DNA binding properties of the human estrogen receptor in vitro and in vivo.
Metzger D; Berry M; Ali S; Chambon P
Mol Endocrinol; 1995 May; 9(5):579-91. PubMed ID: 7565805
[TBL] [Abstract][Full Text] [Related]
16. The carboxy-terminal F domain of the human estrogen receptor: role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists.
Montano MM; Müller V; Trobaugh A; Katzenellenbogen BS
Mol Endocrinol; 1995 Jul; 9(7):814-25. PubMed ID: 7476965
[TBL] [Abstract][Full Text] [Related]
17. Classification of breast cancer cells on the basis of a functional assay for estrogen receptor.
Biswas DK; Averboukh L; Sheng S; Martin K; Ewaniuk DS; Jawde TF; Wang F; Pardee AB
Mol Med; 1998 Jul; 4(7):454-67. PubMed ID: 9713824
[TBL] [Abstract][Full Text] [Related]
18. Synergistic activation of estrogen receptor-mediated transcription by estradiol and protein kinase activators.
Cho H; Katzenellenbogen BS
Mol Endocrinol; 1993 Mar; 7(3):441-52. PubMed ID: 7683375
[TBL] [Abstract][Full Text] [Related]
19. 17 beta-estradiol- and 4-hydroxytamoxifen-induced transactivation in breast, endometrial and liver cancer cells is dependent on ER-subtype, cell and promoter context.
Castro-Rivera E; Safe S
J Steroid Biochem Mol Biol; 2003 Jan; 84(1):23-31. PubMed ID: 12648521
[TBL] [Abstract][Full Text] [Related]
20. hsp70 is not required for high affinity binding of purified calf uterine estrogen receptor to estrogen response element DNA in vitro.
Klinge CM; Brolly CL; Bambara RA; Hilf R
J Steroid Biochem Mol Biol; 1997; 63(4-6):283-301. PubMed ID: 9459195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
